// App-Quantinova.ai

895 : Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation

Researchers

Presenter

  • Rich Kodama

Principal Investigators

  • Amardeep Kalsi

  • Angelica Singh

  • Nivetha Vishnuvardhan

  • Neil Nimkar

  • Sonal Paul

  • Soeb Usta

  • Farah Ashraf

  • Anita Mazloom

  • Abeer Ashfaq

  • Nisha Patel

  • Chathula Kumarasinghe

  • Uqba Khan

  • Peter Gregos

  • Jeremy Weingarten

  • Eshan Patel

Medical Centers

  • New York - Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY

  • New York - Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Myocardial infarction

  • Coronavirus disease

  • Venous thrombosis

  • Sepsis

Biomarkers

  • Body mass index

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved